Effect of Exercises on Hemodialysis
Effect of Intra Dialytic Aerobic Exercises Versus Active Free Exercises on Cognitive Function and Functional Capacity in Hemodialytic Patients
1 other identifier
interventional
69
0 countries
N/A
Brief Summary
o Sixty-nine adult patients from both sexes. They were suffering from ESRD on maintenance hemodialysis, their age ranged from50-60 years old were selected from hemodialysis unit at Itay El Baroud central hospital. They were referred by the physician.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
January 6, 2026
December 1, 2025
4 months
December 9, 2025
December 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fatigue Questionnaire (Fatigue Severity Scale)
The Fatigue Severity Scale it used to assess the level of fatigue. The Fatigue Severity Scale scores range from 9 to 36 where higher scores indicate worse fatigue and lower scores indicate improvement in fatigue.
8 weeks
6-Minutes walk test
The 6-min walk test (6MWT) is frequently used to measure physical function in transplanted patients
8 weeks
Secondary Outcomes (3)
Laboratory investigation (Urea analysis)
8 weeks
The Mini-Cog test
8 weeks
Laboratory investigation (creatinine analysis)
8 weeks
Study Arms (3)
Aerobic exercise
EXPERIMENTAL(23) patients who received aerobic exercise in form of (foot pedal exerciser) for 20 Minutes for each session, 3 sessions per week, for 8 weeks.
Active free range of motion exercise
EXPERIMENTAL(23) patients who received active free range of motion exercise (open kinetic chain active free range of motion) for 20 minutes for each session, 3 sessions per week, for 8 weeks.
control group
OTHER(23) patients who will receive standard medical treatment for end-stage renal disease, including regular hemodialysis sessions and pharmacological management (e.g., Epoetin alfa and phosphate binders) as prescribed by their nephrologist, without participating in the physical therapy exercise program.
Interventions
Foot pedal exerciser: * Simple horizontal foot pedal exerciser used during hemodialysis sessions. * Dual pedals with non-slip straps for foot stability. * Manual resistance adjustment via a single control knob (non-electric). * Provides gradual increase in workload intensity. * Compact and light weight design suitable for use while lying on the dialysis bed. * Enables controlled, low-impact circular movement of the feet. * Aims to improve circulation and strengthen lower limb muscles without requiring active sitting. * Approximate device dimensions: 50 cm (length) x 40 cm (width) x 23 cm (height). * Maximum recommended user weight: 70 kg.
Participants completed the 30-min aerobic exercise sessions during the first 2 hrs. of each dialysis session, 3 times per week for 8 weeks, using a simulated bike riding. Patients will perform active free exercise for upper limb (the arm that hasn't shunt) and lower limbs. Each exercise session consisted of three phases: warm up, conditioning, and cool down.
the control group will receive only the standard medical care provided by dialysis center without any physical therapy intervention
Eligibility Criteria
You may qualify if:
- All patients were included according to the following criteria:
- Age between 50-60years.
- The patients had been on hemodialysis for at least 3 months with three sessions per week for 3-4hr per session.
- The patients were diagnosed with end stage renal failure (stage5 CKD) on maintenance regular HD (three sessions/week (on alternate days), for four hours/session) for more than three months. (Receiving HD through uncomplicated arm arteriovenous (A-V) fistula
- Under medical control
- Both men and women were enrolled
- Body math index ranged from 18,5- 24.9 kg/m²
You may not qualify if:
- Patients who experienced or had one or more of the following were excluded from the study:
- Patients with resting systolic blood pressure \>200 mmHg and/or diastolic blood pressure \>120 mmHg.
- patients with neurological problems (e.g. stroke, head injury)
- patients with musculoskeletal problems (e.g. sever osteoarthritis or difficulties in ambulation)
- Patients with uncontrolled pulmonary disease. (e.g. exaggerated chronic obstructive pulmonary disease, acute asthma)
- Patients with mental health problems and cognitive impairment due to inability to teach them how to make respiratory training.
- Any patient who missed more than two weeks of the program or want to terminate the program.
- Severe obesity (BMI \>35)
- Presence of malignant disease.
- Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis or myocarditis.
- The patients had hearing impairment or mental disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Research Ethical Committee Cairo University
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant of Physical Therapy, Chest Hospital, Damanhour, Elbeheira
Study Record Dates
First Submitted
December 9, 2025
First Posted
January 6, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
January 6, 2026
Record last verified: 2025-12